How should a first‑catch urine specimen be collected and tested for Chlamydia trachomatis and Neisseria gonorrhoeae?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

First-Catch Urine Collection and Testing for Chlamydia and Gonorrhea

For detecting Chlamydia trachomatis and Neisseria gonorrhoeae, collect first-void urine specimens using nucleic acid amplification tests (NAATs), which are the preferred testing method due to their superior sensitivity compared to culture or other methods 1.

Specimen Collection Technique

Timing and Volume

  • Delay collection until at least 2 hours after the patient has last voided 2
  • Collect the first 15-20 mL of voided urine (the initial stream) 3
  • Research demonstrates that the first 4-5 mL contains a sixfold higher organism load compared to later portions of the stream 4

Collection Process

The patient should:

  • Void the initial portion of urine directly into the collection container
  • Stop collection after obtaining the first-void portion (do not collect midstream)
  • This specimen represents urethral washings containing the highest concentration of organisms

Testing Method

Preferred Test: NAATs

NAATs are strongly preferred over culture or hybridization tests for both C. trachomatis and N. gonorrhoeae detection 1. The key advantages include:

  • Higher sensitivity for C. trachomatis detection compared to all other methods 1
  • Can be performed on urine specimens, eliminating the need for invasive urethral swabs 1
  • FDA-cleared for use with male and female urine specimens 5

Performance Characteristics

  • First-void urine examination has 95% sensitivity and 93% specificity for detecting culture-positive urethritis 3
  • NAATs detect 91.8% of infections using first-catch urine in males 4
  • The predictive value of a positive first-catch urine is 91% 3

Clinical Context

When to Test

Test for both pathogens simultaneously because:

  • Coinfection is common - patients infected with N. gonorrhoeae are frequently coinfected with C. trachomatis 5
  • Both infections are reportable to health departments 1
  • Specific diagnosis improves partner notification and treatment compliance 1

Symptomatic vs Asymptomatic Testing

  • Most chlamydial infections are asymptomatic 6
  • In one study, 12 of 22 culture-positive subjects had no genitourinary symptoms, and 11 of these 12 had C. trachomatis 3
  • First-void urine testing is particularly valuable for identifying symptom-free males with chlamydia-associated urethritis 3

Important Caveats

Limitations of Urine Testing

  • While highly effective for urogenital infections, NAATs are not FDA-cleared for rectal or pharyngeal specimens 5
  • For extragenital sites, laboratories must validate performance under CLIA requirements 6
  • Culture remains preferred for non-genital sites (rectum, pharynx) 5

Alternative Specimen Types

Research shows that self-collected urinary meatal swabs may detect more infections than first-catch urine (35 vs 33 cases for CT, 14 vs 11 for NG) 7, though this approach is not yet standard practice. However, the CDC guidelines prioritize first-void urine as the established, validated method for routine testing 1.

Quality Assurance

Without proper collection technique, >10% of specimens may be unsatisfactory due to containing secretions but lacking adequate cellular material 2. The 2-hour voiding delay is critical to ensure adequate organism concentration in the first-void specimen.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.